Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. - Wikidata - awgldk - TriplyDB

Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.

Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.

http://www.wikidata.org/entity/Q34568305

about

Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report Advanced techniques using contrast media in neuroimaging CCSVI and MS: no meaning, no fact White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis Systematic imaging review: Multiple Sclerosis Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics Multiple sclerosis: molecular mechanisms and therapeutic opportunities Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.MRI in multiple sclerosis: current status and future prospects Regional MRI perfusion measures predict motor/executive function in patients with clinically isolated syndrome Influence of Circulating Endothelin-1 and Asymmetric Dimethylarginine on Whole Brain Circulation Time in Multiple Sclerosis.X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model.Energy failure in multiple sclerosis and its investigation using MR techniques.Vascular pathology in multiple sclerosis: mind boosting or myth busting?Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency.Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status.Interleukin-1 and acute brain injury.Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures Brain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce.Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.Characterization of microcirculation in multiple sclerosis lesions by dynamic texture parameter analysis (DTPA)Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives.CCSVI is associated with multiple sclerosis.Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.Veins in plaques of multiple sclerosis patients - a longitudinal magnetic resonance imaging study at 7 Tesla.Vascular hypoperfusion in acute optic neuritis is a potentially new neurovascular model for demyelinating diseases.

P2860

Q21245254-82C75D41-1560-4537-B957-20F659094913 Q22252349-EDF4D235-0F06-4C4D-990B-4C13E711D833 Q22252676-31DD099A-FA09-4A91-97D0-1640EC106EB8 Q24642079-22F8011F-F49C-44D8-B077-642EC584DADD Q24649817-F5F98577-AD9E-4598-B142-2AF3BD5A7C0E Q26779905-E4F14F2A-29C4-4C60-802D-68D7C2C32AFA Q26866364-F12A3E5A-EA60-4933-9C36-ED00AE512416 Q26998412-502BFD41-0D96-4A4B-BF3A-881F2F202909 Q27023735-5AC4595C-F939-484C-B810-F15785E49130 Q27027921-8C7677E6-92E7-479D-B6DC-BEF5FB4500E8 Q31015218-DFAC3DEA-7359-4BDD-A789-9BE48F9DF179 Q31161124-9EC184F9-F832-4F0A-8005-5202139F8AD3 Q33345057-CF3BEA05-D777-4FAD-897A-50B28DACC1B3 Q33552393-F78B114D-3DC7-4691-950D-4130192D0BE7 Q33773354-641303FC-762D-4BEF-9F2A-D5BD455B5946 Q33919133-E25059A9-06ED-4A22-95D7-9E3BD0A69BCC Q33928808-40AC9DE7-4146-4285-9240-7C8CE3BFBC3E Q33960741-6E71037D-E14A-4FA7-A9C6-325308A488B5 Q34051741-C654FCF0-03C3-4273-91F8-0F0693F51A15 Q34109028-8A394A62-0A3C-4930-8E8E-F5F05B179919 Q34333921-F8CCA40B-14CA-46B4-BFFF-D5452CD39EAE Q34750423-DF40DE20-D18F-45D8-A3B1-19B625ABCC26 Q35021647-76E9D394-0554-4BBF-862D-BC271C46DA33 Q35056860-A0B2D634-E863-440E-8352-0F8C8CA9D67A Q35182294-2CB9D234-A737-435E-A929-87BECCEF91CD Q35893074-324FE774-DDF8-4897-AD7A-6D3F2B49920C Q36031145-3687E245-616C-45B7-BA43-C4EA129B7BD9 Q36655414-D4C41D94-F72E-42BB-B785-FE296A1D2799 Q36831144-6315F59B-E702-43D8-9F17-FA1E77BB0F06 Q37017890-F99B11E5-52F9-4FB8-BB2E-6416DECECA41 Q37150344-0CEE7502-258C-4499-A7FF-4E078EF83493 Q37172369-467BD606-E73F-4EEE-BB6E-8485C3F8B3AF Q37459845-46037AA8-405D-49AC-A4FF-5B47FC148F47 Q37921764-9BD1C7CC-A344-4A1B-9707-69155B090BA1 Q38042767-6F36D67F-0C56-4008-B640-63D7B60F944D Q38689611-60D92202-499D-44B2-BD19-D79B7E467044 Q39314274-0040B395-A774-45BD-9607-470FFA034938 Q39349758-B2E6EAB9-5C96-4BD9-857E-224C547798A1 Q41027045-AE653D3D-9846-408A-8EF2-6BDD2BDCA8C6 Q41677192-5C8F876D-1480-40FB-B006-1A741DD41FC7

P2860

Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.

http://www.wikidata.org/entity/Q34568305

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Pattern of hemodynamic impairm ...... perfusion MR imaging at 3.0 T.

@ast

Pattern of hemodynamic impairm ...... perfusion MR imaging at 3.0 T.

@en

Pattern of hemodynamic impairm ...... perfusion MR imaging at 3.0 T.

@nl

type

label

Pattern of hemodynamic impairm ...... perfusion MR imaging at 3.0 T.

@ast

Pattern of hemodynamic impairm ...... perfusion MR imaging at 3.0 T.

@en

Pattern of hemodynamic impairm ...... perfusion MR imaging at 3.0 T.

@nl

prefLabel

Pattern of hemodynamic impairm ...... perfusion MR imaging at 3.0 T.

@ast

Pattern of hemodynamic impairm ...... perfusion MR imaging at 3.0 T.

@en

Pattern of hemodynamic impairm ...... perfusion MR imaging at 3.0 T.

@nl

P1433

Q34568305-051F491F-4D50-4E4A-AD89-B9A94FEF5E24

P1476

Q34568305-81E368E8-A0D0-4D02-9562-8930DE5A2037

P2093

Q34568305-0BA4CAA0-682B-4B03-AEEF-83F8524AA1F1

Q34568305-2E97745D-23D5-48C7-8FFD-828CA5C29CE6

Q34568305-573FAB31-E595-405C-92F5-5BE16E8B4C7D

Q34568305-6100EC55-A211-46E1-8598-8E453756498F

Q34568305-75D418F5-C6B9-450E-BF7D-7E4A86D68E7F

Q34568305-7B31B5F1-FD8C-4A43-8DB0-1EA3C53A3D70

P2860

Q34568305-00C9C3FE-5C32-4EC5-896C-EDDF3FBDF5BC

Q34568305-043FEC02-3477-4C76-8754-C9457E6041B3

Q34568305-10DDE408-3C63-42E8-85F4-7F1FED07C9DF

Q34568305-17511CC8-A186-4F75-9B22-611F7DFE0AA6

Q34568305-1F47345D-BD91-4F85-8F5B-E77D63C76022

Q34568305-2C342124-8BD0-4982-B0CA-BD76E5724A0A

Q34568305-2CC9AEFF-5D29-45AF-8E1B-F7B55DDDA84A

Q34568305-3972AF2A-7ACE-4F37-96A5-25DC49C16F27

Q34568305-3B62BA82-D946-4C4C-9281-E6B99145EF92

Q34568305-4375C61A-BF33-4A9F-8340-280B43AE08DF

P304

Q34568305-1E4922AA-1348-4678-8721-44D053DFC013

P31

Q34568305-33622A7A-BE4E-4624-805F-3ADBC27C620C

P356

Q34568305-5FA09278-6ABE-46F2-A79C-E4D60C235EB7

P407

Q34568305-34C3F8C1-1C8B-4A1D-AE22-D549CEEA6C5A

P433

Q34568305-1D3646A6-C846-45C0-8832-10118D8D284A

P478

Q34568305-4F739235-9A78-4F49-A28B-D29FB2A2961B

P50

Q34568305-EB6269F5-C1BB-48E8-ADA9-2B1E4148841F

P577

Q34568305-50BCCB98-94A1-4FAC-AB49-59FB74FE9A51

P5875

Q34568305-F41804E6-F358-4649-A184-90367E83D6EA

P698

Q34568305-21FE1733-C73E-4740-9E72-4A69102DEC71

P921

Q34568305-8D14D49E-FFD0-4EA5-B7D1-1BA739FA5323

Q34568305-BCC43D8D-F598-4BC0-923C-1B7425D70C72

P932

Q34568305-829270AA-9745-4CAB-8E44-E5CFAC1D5E56

P356

J.NEUROIMAGE.2006.08.008

P1433

P1476

Pattern of hemodynamic impairm ...... perfusion MR imaging at 3.0 T.

@en

P2093

Hina Jaggi

http://www.w3.org/2001/XMLSchema#string

James S Babb

http://www.w3.org/2001/XMLSchema#string

Joseph Herbert

http://www.w3.org/2001/XMLSchema#string

Matilde Inglese

http://www.w3.org/2001/XMLSchema#string

Robert I Grossman

http://www.w3.org/2001/XMLSchema#string

Sumita Adhya

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Axonal transection in the lesions of multiple sclerosis

Axonal pathology in multiple sclerosis: relationship to neurologic disability.

Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis.

Cerebral perfusion imaging in acute stroke.

Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

Diffusion MRI in multiple sclerosis.

Contrast agents and cerebral hemodynamics.

P304

1029-1035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROIMAGE.2006.08.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6798827

http://www.w3.org/2001/XMLSchema#string

P698

16996280

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

1752216

http://www.w3.org/2001/XMLSchema#string